Research Article
Construction of a Cuprotosis-Related Gene-Based Model to Improve the Prognostic Evaluation of Patients with Gastric Cancer
Table 1
General clinical data of the two groups of patients.
| Covariates | Type | Total | Test | Train | value |
| Age | ≤65 | 163 (43.94%) | 84 (45.41%) | 79 (42.47%) | 0.7438 | Age | >65 | 205 (55.26%) | 101 (54.59%) | 104 (55.91%) | | Age | Unknown | 3 (0.81%) | 0 (0%) | 3 (1.61%) | | Gender | Female | 133 (35.85%) | 71 (38.38%) | 62 (33.33%) | 0.3655 | Gender | Male | 238 (64.15%) | 114 (61.62%) | 124 (66.67%) | | Grade | G1 | 10 (2.7%) | 4 (2.16%) | 6 (3.23%) | 0.7102 | Grade | G2 | 134 (36.12%) | 65 (35.14%) | 69(37.1%) | | Grade | G3 | 218 (58.76%) | 112 (60.54%) | 106 (56.99%) | | Grade | Unknown | 9 (2.43%) | 4 (2.16%) | 5 (2.69%) | | Stage | Stage I | 50 (13.48%) | 24 (12.97%) | 26 (13.98%) | 0.7072 | Stage | Stage II | 111 (29.92%) | 52 (28.11%) | 59 (31.72%) | | Stage | Stage III | 149 (40.16%) | 80 (43.24%) | 69 (37.1%) | | Stage | Stage IV | 38 (10.24%) | 20 (10.81%) | 18 (9.68%) | | Stage | Unknown | 23 (6.2%) | 9 (4.86%) | 14 (7.53%) | | T | T1 | 18 (4.85%) | 7 (3.78%) | 11 (5.91%) | 0.7283 | T | T2 | 78 (21.02%) | 38 (20.54%) | 40 (21.51%) | | T | T3 | 167 (45.01%) | 83 (44.86%) | 84 (45.16%) | | T | T4 | 100 (26.95%) | 53 (28.65%) | 47 (25.27%) | | T | Unknown | 8 (2.16%) | 4 (2.16%) | 4 (2.15%) | | M | M0 | 328 (88.41%) | 165 (89.19%) | 163 (87.63%) | 0.689 | M | M1 | 25 (6.74%) | 11 (5.95%) | 14 (7.53%) | | M | Unknown | 18 (4.85%) | 9 (4.86%) | 9 (4.84%) | | N | N0 | 108 (29.11%) | 50 (27.03%) | 58 (31.18%) | 0.2444 | N | N1 | 97 (26.15%) | 45 (24.32%) | 52 (27.96%) | | N | N2 | 74 (19.95%) | 40 (21.62%) | 34 (18.28%) | | N | N3 | 74 (19.95%) | 44 (23.78%) | 30 (16.13%) | | N | Unknown | 18 (4.85%) | 6 (3.24%) | 12 (6.45%) | |
|
|